FORWARD-COVID 19 Supplement
FORWARD-COVID 19 补充资料
基本信息
- 批准号:10189267
- 负责人:
- 金额:$ 25.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAdherenceAdultAdvocacyAffectAllergensAllergic ReactionAmericanAmericasAnaphylaxisAnxietyAsiansAsthmaBehaviorBiological AssayBusinessesCOVID-19COVID-19 pandemicCaregiversCaringChildChild CareChildhoodClinicClinic VisitsClinicalDataDecision MakingDiagnosisDisease ManagementEczemaEducationEmergency CareEmergency department visitEmergency medical serviceEnrollmentEpinephrineFamilyFoodFood HypersensitivityFoundationsFutureGoalsGuidelinesHealthHealth PolicyHealthcareHispanicsHome environmentHouseholdHypersensitivityImpairmentIndividualKnowledgeLaboratoriesLifeLiteratureMeasuresMedicalMethodologyMethodsMovementOutcomeParentsPatient Self-ReportPatientsPatternPharmaceutical PreparationsPhenotypePopulationPractice ManagementPrevalenceProspective StudiesPublic HealthPublishingQuality of lifeReportingResearchResourcesSamplingSchoolsSeveritiesSiteSocial DistanceSurvey MethodologySurveysTechniquesTelemedicineUnited StatesUniversitiesVisitbasebullyingburden of illnesscohortcomorbiditycostdata registrydesigneditorialexperiencefood environmenthealth care service utilizationmedical schoolspandemic diseasepathogenic viruspatient populationpatient registrypeerpreventpsychosocialpublic health interventionracial differenceracial disparityracial diversityresponsesample collectiontreatment optimization
项目摘要
PROJECT SUMMARY/ABSTRACT
Background: Food allergy (FA) is a potentially life-threatening condition that affects an estimated 8% of
children in the United States. Although differences between Black and White children in the prevalence and
severity of other atopic conditions such as asthma and eczema have been well described, little is known about
such differences in FA. The limited existing literature indicates that Black children may have worse clinical
outcomes, including rates of FA-related fatal anaphylaxis and FA-related emergency department (ED) visits,
than their White peers. Phenotypic and endotypic differences, including rates of sensitization and co-
morbidities, between Black and White children are beginning to be examined. Data on racial differences in FA
management practices are incomplete; preliminary data suggest that Black families spend significantly less on
allergen-free foods and FA medications than do White families. Families caring for children with FA experience
significant impairments in psychosocial outcomes, including FA-related quality of life (FAQoL); however, these
data come primarily from White, privately insured families, and little is known about psychosocial outcomes in
Black families. Two recent reviews concluded that existing studies examining racial disparities in FA are far too
methodologically limited to draw definitive conclusions, primarily due to reliance on self-report of FA diagnosis
and cross-sectional designs.
Specific Aims and Methods: Our goal is to prospectively study a cohort of 800 Black and White children (0-
12 years) with FA in order to: 1) Determine variability in clinical FA outcomes between Black and White
patients via quarterly online assessments, annual clinic visits, and medical chart review over a two-year period;
2) Examine phenotypic and endotypic differences between Black and White children with FA using specific
laboratory specimen collection techniques and assays; 3) Identify differences between Black and White
children in FA management practices by parent report (e.g. allergen avoidance and epinephrine carriage);
and 4) Determine differences between Black and White children in psychosocial FA-related outcomes
(e.g., FA-related quality of life, bullying, anxiety, and worry) via the above survey methods.
Hypotheses and Expected Results: We hypothesize that compared to White children, Black children will:
have higher rates of food-allergic reactions and FA-related healthcare utilization; demonstrate unique FA
phenotypes and endotypes; have less knowledge of FA management and less adherence to preventative
behaviors; have limited access to medications and allergen-free foods; and report better quality of life.
Significance and Effects on Other Research: Confirming and further characterizing differences
between Black and White children with FA will provide the data required to develop clinical guidelines,
optimize treatment, and build health policies that meet the needs of both Black and White children.
项目概要/摘要
背景:食物过敏 (FA) 是一种可能危及生命的疾病,影响估计 8% 的人
在美国的孩子们。尽管黑人和白人儿童在患病率和
哮喘和湿疹等其他特应性疾病的严重程度已得到充分描述,但人们知之甚少
FA 的这种差异。有限的现有文献表明黑人儿童的临床症状可能更差
结果,包括与 FA 相关的致命过敏反应和与 FA 相关的急诊科 (ED) 就诊率,
比他们的白人同龄人表型和内型差异,包括致敏率和协同率
黑人和白人儿童之间的发病率正在开始受到检查。 FA 中种族差异的数据
管理规范不完善;初步数据表明,黑人家庭在以下方面的支出明显减少
与白人家庭相比,他们使用不含过敏原的食品和 FA 药物。照顾具有 FA 经验的儿童的家庭
心理社会结果显着受损,包括 FA 相关的生活质量 (FAQoL);然而,这些
数据主要来自白人、私人保险家庭,人们对心理社会结果知之甚少。
黑人家庭。最近的两项评论得出的结论是,现有的研究 FA 种族差异的研究太过分了。
方法论上仅限于得出明确的结论,主要是由于 FA 诊断的自我报告的依赖
和横截面设计。
具体目标和方法:我们的目标是前瞻性研究 800 名黑人和白人儿童(0-
12 年)与 FA 合作,以便:1)确定黑人和白人之间临床 FA 结果的变异性
通过两年内的季度在线评估、年度门诊就诊和病历审查对患者进行评估;
2) 使用特定的方法检查患有 FA 的黑人和白人儿童之间的表型和内型差异
实验室标本采集技术和化验; 3)识别黑人和白人之间的差异
家长报告中儿童的 FA 管理实践(例如避免过敏原和携带肾上腺素);
4) 确定黑人和白人儿童在 FA 相关社会心理结果方面的差异
(例如,与 FA 相关的生活质量、欺凌、焦虑和担忧)通过上述调查方法进行。
假设和预期结果:我们假设与白人儿童相比,黑人儿童将:
食物过敏反应和 FA 相关医疗保健利用率较高;展示独特的FA
表型和内型;对 FA 管理的了解较少,对预防措施的遵守程度较低
行为;获得药物和无过敏原食品的机会有限;并报告更好的生活质量。
对其他研究的意义和影响:确认并进一步表征差异
患有 FA 的黑人和白人儿童将提供制定临床指南所需的数据,
优化治疗并制定满足黑人和白人儿童需求的卫生政策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ruchi S Gupta其他文献
Ruchi S Gupta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ruchi S Gupta', 18)}}的其他基金
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
- 批准号:
10212208 - 财政年份:2019
- 资助金额:
$ 25.34万 - 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
- 批准号:
10425291 - 财政年份:2019
- 资助金额:
$ 25.34万 - 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
- 批准号:
9982763 - 财政年份:2019
- 资助金额:
$ 25.34万 - 项目类别:
Intervention to Reduce Early (Peanut) Allergy in Children (iREACH)
减少儿童早期(花生)过敏的干预措施 (iREACH)
- 批准号:
10666514 - 财政年份:2019
- 资助金额:
$ 25.34万 - 项目类别:
Food Allergy Management and Outcomes Related to Racial/Ethnic Differences from Infancy through Adolescence: The FORWARD Study
食物过敏管理和与从婴儿期到青春期的种族/民族差异相关的结果:FORWARD 研究
- 批准号:
10446840 - 财政年份:2017
- 资助金额:
$ 25.34万 - 项目类别:
Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD)
与白人和非裔美国人种族差异相关的食物过敏结果(转发)
- 批准号:
9398764 - 财政年份:2017
- 资助金额:
$ 25.34万 - 项目类别:
Food Allergy Management and Outcomes Related to Racial/Ethnic Differences from Infancy through Adolescence: The FORWARD Study
食物过敏管理和与从婴儿期到青春期的种族/民族差异相关的结果:FORWARD 研究
- 批准号:
10580069 - 财政年份:2017
- 资助金额:
$ 25.34万 - 项目类别:
Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD)
与白人和非裔美国人种族差异相关的食物过敏结果(转发)
- 批准号:
9922208 - 财政年份:2017
- 资助金额:
$ 25.34万 - 项目类别:
FORWARD Supplement: Common Data Elements for Food Allergy
FORWARD 补充:食物过敏的通用数据元素
- 批准号:
10868981 - 财政年份:2017
- 资助金额:
$ 25.34万 - 项目类别:
Improving Food Allergy Management through an Electronic Physician Support Tool
通过电子医生支持工具改善食物过敏管理
- 批准号:
8584033 - 财政年份:2013
- 资助金额:
$ 25.34万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 25.34万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 25.34万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 25.34万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 25.34万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 25.34万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 25.34万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 25.34万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 25.34万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 25.34万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 25.34万 - 项目类别:














{{item.name}}会员




